A Multicenter, Randomized, Open-Label, Phase 3 Study of Doripenem Versus a Comparator Antibiotic in the Treatment of Ventilator-Associated Pneumonia.
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Doripenem; Imipenem
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 06 Jun 2008 EMEA approved intital MAA for the treatment of adults with nonsocomial pneumonia.
- 04 Oct 2007 Status change from in progress to completed.
- 20 Sep 2007 Results have been reported at ICAAC 2007
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History